Source: Virtual Congress 2020 – Antibiotic resistance: the way forward
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
V. Nizet (La Jolla, United States of America). Improving the innate immune response in respiratory infections: the use of repurposed drugs. Virtual Congress 2020 – Antibiotic resistance: the way forward

Member's Comments

No comment yet.

Related content which might interest you: Trained immunity: a way of improving respiratory health through innate immune memory Source: International Congress 2019 – Scientific Year in review Year: 2019 The innate defence peptide BPIFA1/SPLUNC1 restricts respiratory viral infections Source: International Congress 2019 – Infections, the microbiome and host defence peptides in the development and progression of asthma Year: 2019 Oral presentation: Targeting of microRNAs can restore innate anti-viral response in asthma Source: Lung Science Conference 2014 - Lung Inflammation and Immunity Year: 2014 Influence of innate immunity on respiratory disease development and vaccination process Source: Eur Respir J 2006; 28: Suppl. 50, 341s Year: 2006 Relevance of innate immune responses to chronic airway diseases Source: Annual Congress 2008 - The battle between environmental “invaders” and airway epithelial defences Year: 2008 Prenatal priming on neonatal innate and adaptive immune responses by the farming environment Source: Annual Congress 2005 - Environmental factors, allergy and asthma Year: 2005 Overview of innate and adaptive immune responses in the airways Source: Virtual Congress 2021 – Pharmacology of lung immune responses: which pathways to target! Year: 2021 Modulation of the innate and adaptive immune system during coronavirus infection. Source: Virtual Congress 2021 – Emerging respiratory diseases: state-of-the-art studies of SARS-CoV-2 infection Year: 2021 Immunology and defence mechanism of the developing lung Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=60 Year: 2006 Innate and adaptive immune response in lung diseases Source: International Congress 2019 – PG6 Immunodeficiencies in lung diseases Year: 2019 Cationic host defence peptides as a novel treatment for respiratory viral infections Source: International Congress 2018 – Antimicrobial host defence and innate immunity in the lung Year: 2018 Assessment of humoral immune response and the incidence of acquired infections in asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 174s Year: 2003 ICS/LABA effects on antiviral innate immune response. An in vitro analysis. Source: International Congress 2019 – Novel targets and mechanisms in asthma Year: 2019 Can the immune system be targeted to treat COVID-19? Source: Eur Respir Monogr 2021; 94: 69-85 Year: 2021 LSC - 2019 - Azithromycin modulates viral-induced asthma exacerbation by targeting the innate immune response Source: International Congress 2019 – Revealing novel asthma immunopathology endotypes Year: 2019 Socioeconomic environment, humoral immune response and the incidence of acquired infections Source: Eur Respir J 2003; 22: Suppl. 45, 174s Year: 2003 Innate immunity in the lung: how epithelial cells fight against respiratory pathogens Source: Eur Respir J 2004; 23: 327-333 Year: 2004